Showing 1181-1190 of 3017 results for "".
Experts React to Latest Benzene Analysis
https://practicaldermatology.com/series/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvDermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approves-humira-biosimilar-study-examines-trifarotene-acne-lesions/24513/In this episode of DermwireTV, the FDA approves a high-concentration Humira biosimilar; a study finds trifarotene combined with a skincare regimen was effective for acne-induced hyperpigmentation; the FDA accepts Dermavant's NDA for Vtama cream for AD; and the PA Perspective series addresses buildinUnplugged: Cutting-Edge Aesthetic Medicine
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/unplugged-cutting-edge-aesthetic-medicine/20142/Jeanine Downie, MD shares pearls from her presentation in the Unplugged session she co-chaired with José Montes, MD. She discusses some of the latest tightening devices for the face, neck, and body, including EmFace, Zaffiro, and Sofwave. Plus, she reviews topics presented by colleagues throughout tDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)DermWire TV: Adbry Approved; Syringoma Option; Confusion over Vaccines and Injectables
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-adbry-approved-syringoma-option-confusion-over-vaccines-and-injectables/20041/Adbry (tralokinumab) from Leo Pharma is the newest biologic approved for moderate to severe atopic dermatitis in adults and is the first IL-13 blocker approved in the US. Pulse Bioscience’s nano-pulse stimulation (NPS) technology shows potential for the treatment of syringoma in a feasibility studyHow Will You Pay for Taxes in Retirement
https://practicaldermatology.com/topics/practice-management/how-will-you-pay-for-taxes-in-retirement--hgsepipo/18365/OJM Group Director of Financial Advisors Michael Lewellen, CFP presents an effective hedging strategy that can help you build retirement wealth while reducing your tax burden during your retirement years. Click here to request or download a free copy of Wealth Protection Planning for DermatologistsJoel Schlessinger MD Discusses Personal Phones in the Office
https://practicaldermatology.com/topics/practice-management/joel-schlessinger-md-discusses-personal-phones-in-the-office-/19276/Dealing with personal phone use at work is an issue that almost every business must consider. While it is important that people are available in case of an emergency, this rule can often be abused. In this video, Joel Schlessinger MD offers his advice on dealing with this office issue. Dr. Joel STaking a More Holistic View of the Pathogenesis of Acne
https://practicaldermatology.com/topics/acne-rosacea/taking-more-holistic-view-pathogenesis-acne/26539/Taking a More Holistic View of the Pathogenesis of AcneUnleashing Revenue Growth:Harnessing Patient Data
https://practicaldermatology.com/topics/practice-management/unleashing-revenue-growth-harnessing-patient-data/26968/Unleashing Revenue Growth: Harnessing Patient DataExpanding Horizons in Skin Cancer Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/expanding-horizons-in-skin-cancer-treatment/18704/In Part 2 of this episode of Derm Insider, Host Neal Bhatia asks Anisha Patel, MD and Anthony Rossi, MD about advances in skin cancer therapies. Dr. Rossi discusses how to decide on the best regimens for the type of tumor being treated, and the importance of chemoprevention. They also talk more abou